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ABSTRACT  
The analysis of Tumor Interstitial Fluid (TIF) composition is a valuable procedure to 
identify anti-metastatic targets, and different laboratories have set up techniques for TIF 
isolation and proteomic analyses. However, those methods had never been compared 
in samples from the same tumor and patient. In this work, we compared the two most 
used methods, elution and centrifugation, in pieces of the same biopsy samples of 
cutaneous squamous cell carcinoma (cSCC). First, we established that high G-force 
(10000g) was required to obtain TIF from cSCC by centrifugation. Secondly, we 
compared the centrifugation method with the elution method in pieces of three different 
cSCC tumors. We found that the mean protein intensities based in the number of peptide 
spectrum matches was significantly higher in the centrifuged samples than in the eluted 
samples. Regarding the robustness of the methods, we observed higher overlapping 
between both methods (77-80%) than among samples (50%). These results suggest that 
exists an elevated consistence of TIF composition independently of the method used. 
However, we observed a three-fold increase of extracellular proteins in non-overlapped 
proteome obtained by centrifugation. We therefore conclude that centrifugation is the 
method of choice to study the proteome of TIF from cutaneous biopsies.  
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INTRODUCTION 
Tumor-host interface signals are key elements to explain the induction and development 
of metastasis1. It seems clear that tumor-bearing extracellular signals are involved in 
most of metastatic steps such as stroma invasion and pre-metastatic niche preparation. 
This metastatic signaling is mediated by cancer-secreted metabolites and proteins. The 
secretome of a cell encompasses all the components secreted by this cell including 
metabolites, proteins and exosome vesicles. The cancerous secretome can be obtained 
from the tumor interstitial fluid (TIF). This fluid is bathing the tumor and stroma cells and 
represents the tumor milieu2. Therefore, the proteomic study of TIF is an approach of 
special interest that could reveal key molecules involved in the infiltrative or metastatic 
capacity of the neoplasia and could have potential consequences for developing 
biomarkers or therapeutic targets3-4.  
Proteomic analyses are well established methodologies for studies of molecular 
oncology5. However, these methods require a considerable effort to set up every step of 
the workflow in order to minimize pre-analytical and analytical variability. The main goal 
is to perform reproducible experiments and to obtain reliable lists of protein candidates. 
The initial step in the workflow is the sample preparation. Definitely, the quality of the 
starting material is a major prerequisite for the final-result quality. In addition, it is 
important to consider that sample preparation is not automated in most of the 
experiments6. Then, this step is one of the main sources of experimental variability7.  
Different techniques have been used for TIF isolation and proteomic analysis in different 
tumors3. It is because the choice of the right method for TIF isolation is not easy since it 
depends on many variables8. For instance, it is important to consider such diverse issues 
as the analytical purpose of the experiment, the amount of cell breakage or the volume 
recovered. Lacking a generally accepted method for TIF sampling, in this work, we have 
assayed the two most used methods of TIF isolation, elution and centrifugation, in the 
same biopsies of cutaneous squamous cell carcinoma (cSCC). This cancer is the second 
most common non-melanoma skin cancer and the second most common tumor in 
humans, and no proteomic study on its TIF has been conducted to date.  
EXPERIMENTAL SECTION 
Human cutaneous squamous cell carcinoma samples 
The study was conducted following the basic principles (respect for the individual), 
operational (risk-benefit) and guidelines (good clinical practice) of the Declaration of 




   
 
surplus and were collected after obtaining the written informed consent of the patient and 
with the approval of the Ethics Committee for Scientific Research (CEIC) of HUAV-UdL. 
The samples were managed by the Biobank of IRB Lleida authorized by the Department 
of Health of Catalonia dated 29 April 2013 and registered in the National Register of 
Biobanks of the Carlos III Institute of Health with B.0000682 reference number. The 
Biobank guarantees the conditions of traceability, quality and safety of the samples with 
the proper controls. 
Three surplus biopsies of cSCC from patients were obtained after surgical resection and 
extensively washed with a sterile dressing to eliminate blood clots. The tumor samples 
were from the tumor surface, in an area without any apparent necrosis or inflammation. 
Immediately, the tissue was collected with sterile forceps and put on a plate (6-well) with 
1 ml of PBS. The forceps was used to gently shake the tissue in the PBS and the washing 
was repeated three times. The tissue was cut into two equal halves in volume and tissue 
characteristics.  
Elution method 
For large biopsies (>0.2 gr), tissue was carefully cut into small pieces (0.1 gr) avoiding 
as long as possible cell damage with the minimum manipulation. The cutting of tissue 
was done while keeping it in a full of PBS plate, in order to avoid TIF evaporation. Then, 
eluted in 750 µl of PBS containing protease and phosphatase inhibitors (PBSi) for 2 
hours at 37ºC and 5% CO2. Finally, 500 μl of PBSi were collected and filtered (0.45 μm) 
to avoid cells contamination. The final sample was stored at -80ºC until the proteomic 
analysis. The cocktail of protease and phosphatase inhibitors (cOmplete™, EDTA-free 
Protease Inhibitor Cocktail) was purchased at Roche. 
 
Centrifugation method 
In this method, biopsy was blotted gently with tissue paper to remove excess of PBS and 
transferred to 2 ml centrifuge tubes (Clearspin 2 ml tubes. 0.45 mm Cellulose acetate 
membrane. Sterile ClearLine (Ref 007859ACL)) used for TIF isolation. These two steps 
were carried out quickly to avoid evaporation from the tissue. Immediately, the samples 
were centrifuged at 10000 g for 20 minutes at 4ºC (Eppendorf, 5415R), recovering 5-15 
µl accumulated in the bottom of the tube. PBSi was added for a final volume of 50 µl. 






   
 
TIF proteins from each method were separated on a 10% SDS-PAGE gel. To visualize 
protein bands, the gel was stained with Coomassie Blue reagent. The protein profile of 
the samples was obtained with the plot profile of Image J program.  
 
Proteomic analysis of the samples    
Protein extraction, quantification and digestion 
The TIFs were mixed with 6M Urea / 200mM Ammonium Bicarbonate (ABC) to help the 
proteins to be solubilized and then quantified with the RCDC Protein Assay kit (Biorad, 
#5000-120). Ten μg of protein from each sample were digested in-solution using both 
LysC and Trypsin. Briefly, the samples were reduced with 10mM dithiothreitol (DTT, in 
200mM ABC) for 1h at 37ºC and 650 rpm in the thermo-mixer, alkylated with 20 mM 
iodoacetamide (IAA, in 200mM ABC) for 30 minutes at room temperature in the dark at 
650 rpm in the thermo-mixer. Then, samples were diluted to have them at 2M Urea final 
concentration and the required amount of 1μg/μl LysC (WAKO, #125-05061) was added 
to have a 1:10 ratio enzyme:protein (w:w). The digestion was performed overnight at 
37ºC at 650 rpm in the thermo-mixer. After that, samples were diluted again to have them 
at 1M Urea final concentration. Finally, the required amount of 1μg/μl trypsin 
(sequencing-grade, Promega, #V5280) was added to have a 1:10 ratio enzyme:protein 
(w:w) and incubated for 8h at 37ºC at 650 rpm in the thermo-mixer. 
Peptide desalting 
Peptide mixtures were desalted using the commercial columns Ultra Microspin C18, 
300A silica (The Nest Group, #SUM SS18V) according to the manufacturer instructions.  
Finally, the samples were dried in a SpeedVac and kept at -20ºC until the LC-MS/MS 
analysis. 
LC-MS/MS analysis 
Samples were analyzed in a Proxeon 1000 liquid chromatographer coupled to an 
Orbitrap Fusion Lumos (Thermo Fisher Scientific) mass spectrometer. Samples were re-
suspended in 45 microliters of 0.5% formic acid in water, and 4.5 μl (2 micrograms) were 
injected for LC-MSMS analysis. Peptides were trapped on an NTCC-360/75-3-123 LC 
column and separated using a C18 reverse phase LC column-Easy Spray (Thermo 
Fisher Scientific). The gradient used for the elution of the peptides was 1% to 35% in 
90min followed by a gradient from 35% to 85% in 10 min with 250nL/min flow rate. Eluted 




   
 
Objective, Scientific Instrument Services, Ringoes, NJ, USA) with an applied voltage of 
2,000 V. Peptide masses (m/z 300-1700) were analyzed in data-dependent mode where 
a full scan MS was acquired on the Orbitrap with a resolution of 60,000 FWHM at 400 
m/z. Up to the 10 most abundant peptides (minimum intensity of 500 counts) were 
selected from each MS scan and then fragmented using CID (collision-induced 
dissociation) in the linear ion trap using helium as collision gas with 38% normalized 
collision energy. The scan time settings were: full MS at 250ms and MSn at 120ms. 
Generated .raw data files were collected with Thermo Xcalibur (v.2.2) (Termo Fisher 
Scientific). 
Proteomic Data Analysis 
Raw data processing and database search 
Proteome Discoverer software suite (v2.0, Thermo Fisher Scientific) and the Mascot 
search engine (v2.5, Matrix Science) were used for peptide identification and 
quantification. Samples were searched against a SwissProt database containing entries 
corresponding to Human (version of March 2018) a list of common contaminants and all 
the corresponding decoy entries. Trypsin was chosen as enzyme and a maximum of 
three miscleavages were allowed. Carbamidomethylation (C) was set as a fixed 
modification, whereas oxidation (M) and acetylation (N-terminal) were used as variable 
modifications. Searches were performed using a peptide tolerance of 7 ppm and a 
product ion tolerance of 0.5 Da. Resulting data files were filtered for FDR <1%. The raw 
data as well as the processed files were uploaded to the PRIDE repository with the 
project accession code PXD016261.  
Bioinformatic analysis  
The handling of the protein lists created with Proteome Discoverer as well as the 
generation of the Venn diagrams and bar plots were performed with R (3.5.2) and R 
Studio (1.1.419) with the help of the “Vennerable” package. 
Gene Ontology enrichment analysis 
The Gene Ontology enrichment analysis was performed with the DAVID Bioinformatics 
tools9 (https://david.ncifcrf.gov/) using the “Functional Annotation” functionality. For this 
analysis, all the levels of specificity of the “Cellular Compartment” Ontology were 
selected (GOTERM_CC_ALL) and the “Functional Annotation Clustering” option was 




   
 
significance (EASE score) was set to 0.001. The enriched GO terms related to the 
different cell compartments were extracted using R (3.5.2) and R Studio (1.1.419).    
RESULTS AND DISCUSSION 
TIF sample processing by centrifugation.  
The amount of tissue is typically limited for the surplus biopsies of cSCC (0.1-0.3 gr). In 
this work, we split each tumor sample into two halves of about 0.1 gr and used each one 
in a different procedure of TIF extraction. First, we set up centrifugation method10-11. Key 
steps in this method were centrifugation parameters like G-forces and time of 
centrifugation. Excessive G-forces and time could cause the rupture of cells and hence 
the contamination of interstitial fluid with intracellular proteins. Certainly, these 
parameters had to be considered taking into account the particular characteristics of 
each tissue. In our hands, we needed high G-forces to obtain TIF from cSCC samples. 
Below 800 g, the volume recovered was always less than 1 μl. At 800 g for 20 minutes, 
the volume of the sample was less than 5 μl depending on the sample size. We got 
satisfactory volumes in all samples (5 to 15 μl) after spinning at 10.000 g for 20 minutes. 
All the samples were diluted with PBS containing protease inhibitors (iPBS) to a final 
volume of 50 μl with a protein concentration ranging from 5 to 30 mg/ml.  
We compared the protein profiles obtained at 800 g and 10000 g from one tumor sample 
(SCC19). Both procedures showed similar profiles enriched in low molecular weight 
proteins when compared to plasma (Figure 1A-1B). To visualize the influence of G-force 
on proteome composition, two tumor samples (SCC18 and SCC19) each of them 
centrifuged at low and high revolutions (four samples in total) were analyzed by mass 
spectrometry. The Venn diagrams show the overlap of the identified proteins from the 
two spin conditions (Figure 2A-2B). The 90% of the proteins identified at 800 g were also 
found at 10000 g indicating that high G-force did not imply a loss of information. To 
analyze the variability among methods and samples, we calculated the Pearson 
correlation coefficient (PCC) of the mass spectrometry results. The heat map of PCC 
showed that the secretomes of different samples had a larger variation than the ones 
from distinct centrifugation conditions (Figure 2C), meaning that the biological variability 
clearly exceeded the technical variability.  
Finally, we considered the risk of cell breakage in the 10000 g samples. In the samples 
SCC18 and SCC19, there were 136 and 122 proteins only identified at 800 g, whereas 
at 10000 g there were 292 and 362 not overlapped proteins, respectively (Figure 2A - 
2B). We determined the percentage of GO terms related to subcellular localization of 




   
 
level of nuclear and membrane proteins in the samples obtained at 10000 g that would 
have pointed towards an increased cell breakage at higher centrifugation speed.   
Additionally, we performed a semi-quantitative analysis of ribosomal proteins (based on 
the signal of 78 ribosomal proteins) using the PSMs detected in both extraction methods 
(elution and spin at 10000 g) which also show no statistical differences (Supplementary 
Table 2) indicating that the cell breakage is similar regardless of the methodology used. 
The list of ribosomal proteins included in the analysis are listed in Supplementary Table 
3). 
In order to determine spin method and LC-MS/MS analysis variability, we have 
performed technical replicates. The same tumor sample was split in two halves (SPIN1 
and SPIN2) and each of them were processed for TIF extraction with the same spin 
protocol (10000 g; 20 min). The whole proteome obtained from SPIN2 sample was 
injected three times for LC-MS/MS analysis. The LC-MS/MS replicates showed 96-97% 
overlap suggesting a very good reproducibility (Suppl. Figure S1). Moreover, there is a 
high overlap (more than 95%) among the single technical replicate injected for SPIN1 
and each of the three replicates injected for SPIN2 (Suppl. Figure S2).  
Overall, these results indicate that the increment of G-force necessary to obtain TIF in 
samples of cSCC results in the identification of more proteins but it seems that does not 
trigger a strong generalized cell breakage, compared to lower G-forces or elution 
method. The requirement of this high G-force could be explained because the human 
skin is a very collagen-rich tissue, and the collagen alone accounts for approximately 
75% of the dry weight of skin12, providing it with a high tensile strength not present in 
other tissues.  
 
Comparison of the proteomes generated by elution and spin methods 
To obtain TIF samples by elution, we essentially used the procedure published by Celis 
et al 13. In this method, the protein composition of the fluid depends on the diffusion of 
the proteins from the interstitium to the PBS. Since the interstitium of the skin is very rich 
in collagen and therefore quite dense13, we incubated the tissue for two hours instead of 
one to extend the diffusion time in iPBS. Also, we incubated pieces of about 0.1 gr 
avoiding cutting tissue and thus reducing cell break. For all the samples, we recovered 
500 μl of final volume with a protein concentration that ranged from 3 to 10 mg/ml. We 
tested the quality of the samples by SDS-PAGE and coomassie blue staining (Figure 1C 




   
 
and was enriched mainly with low molecular weight proteins (below albumin) 
independently of the method used.  
To compare elution and centrifugation (10000 g) methods, three tumor samples (SCC6, 
SCC8 and SCC9) each of them eluted and centrifuged (six samples in total) were 
analyzed by mass spectrometry. The total number of proteins identified was 2767 
proteins by the elution method and 2869 by the spin method. The 88-89% of the proteins 
identified by spin and elution methods are found in extracellular vesicles (Vesiclepedia 
database, last version15) supporting TIF samples quality (Suppl. Figure S3; Suppl. Tables 
S4 and S5). The observed mean proteins intensities in every sample of spin method 
were significantly higher than the ones observed by elution method (Figure 3A). As a 
loading control, we have compared the PSMs found for some of the most abundant 
plasma proteins (Suppl. Table 1). As observed, none of the PSMs comparisons are 
statistically significant (rows 2 to 5) suggesting that the amounts of the most abundant 
proteins detected in both methods are indistinguishable. However, the comparison of the 
mean intensities (row 1) of both methods shows differences which are statistically 
significant (p<0.005). This would indicate that although the amount of proteins/peptides 
analyzed in every sample is similar the method B seems to improve the detection of 
proteins as observed in comparing the mean intensities.  
Considering sample variability, only around 50% of proteins (52.7% and 52.6% in elution 
and spin method, respectively) were identified in all the three samples analyzed with the 
same method (Figure 3B - 3C). Multiple previous studies showed similar results: 
analyzing different biological samples of one tumor type other authors also found 50% 
of common proteins among samples15-16. The biological samples variability between 
different patients could be explained for multiple reasons, foremost tumor heterogeneity 
and characteristics of the patient. Our three patients were diagnosed of primary high risk 
cSCC with similar clinical and pathological characteristics, but each tumor may differ in 
their individual genetic and therefore also proteomic profile. All tumors were sampled 
from a chronically photoexposed area, but not exactly the same area: the face (SCC6), 
the wrist (SCC8) and the scalp (SCC9) (Table 1).  
Regarding methods, the overlap among the total proteins obtained from the three 
samples in each method was 80.01% of proteins found by elution method and 77.17% 
of total proteins found by spin method (Figure 3D). The Pearson correlation coefficients 
indicate that the proteomes of different samples showed higher variability than the 
proteomes of different methods (Figure 3E). This result suggests that the methodology 
used in TIF extraction, centrifugation versus elution, does not strongly influence the 




   
 
relatively important number of proteins (553 of eluted proteins and 655 of spin-obtained 
proteins) were specific for each individual method. We analyzed the subcellular 
localization of method-specific proteins by using GO ontology classification (Figure 3F). 
The GO terms related to “nuclear” and “membrane” localizations were considerably 
increased (more than 10-fold and 6-fold increase, respectively) in the elution method 
whereas the “extracellular” localization was enriched in the spin method (around 3-fold 
increase). This last result suggests that centrifugation is the suitable method to obtain 
TIF samples from cSCC. 
To our knowledge this is the first study comparing the methodologies used to obtain TIF 
in samples of the same patient and tumor. We have checked in the literature for dataset 
of TIF of the same kind of tumor processed with elution or centrifugation. For instance, 
the proteomic analysis of TIF of ovarian carcinoma obtained by Hoskins et al16 using 
elution and by Haslene-Hox et al11 using centrifugation. In these studies, 569 total 
proteins were obtained using elution and 769 using centrifugation and 284 of the proteins 
were common to both methods. This means an overlap of 50% in elution and 37% in 
centrifugation. Although these studies are not directly comparable with our results, the 
number of proteins obtained with centrifugation method is also higher. Moreover, 
considering the differences among patients, tumors and mass spectrometry set up, the 




In this paper, we suggest a “workflow” to set up TIF isolation in tumor tissues that 
includes the comparison of different methods with pieces of the same tumor. Protocol 
characteristics may be set up for each tumor. The choice of a method rather depends on 
the consistency and the handling of the tissue, than on method quality as such. We 
propose that centrifugation is the method of choice to obtain TIF in cSCC biopsies. We 
got more extracellular proteins, greater sensitivity and easier and quicker handling of 
samples. The spin method is very well adjustable to the mean size of the cSCC biopsies. 
The main concern associated to the centrifugation method is cell breaking during the 
spin of the biopsy at high G-forces10-11. However, our data indicate that the level of cell 
integrity after spin (10000 g) or after elution may be very similar because the proteome 
profile was quite conserved. Moreover, centrifuged samples showed low levels of nuclear 
and membrane proteins and enrichment in extracellular proteins. Then, these data 
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Figure 1. Sample processing. A) TIF samples of the same biopsy SCC19 obtained by 
spin at 800 g (5 µl) and at 10000 g (2.5 µl) were analyzed by SDS-PAGE in 10% 
polyacrylamide gel. Picture of the gel stained with Coomassie Blue. B) Protein profile 
obtained from A with the Image J program. C) TIF samples of the same biopsy SCC6 
obtained by elution (7.5 µl) and by spin (5 µl) were analyzed by SDS-PAGE in 10% 
polyacrylamide gel. Picture of the gel stained with Coomassie Blue. D) Protein profile 
obtained from C with the Image J program.  
A molecular weight standard (st) and plasma were also loaded in the gel as controls. 
High and Low Molecular Weight regions are indicated as HMW and LMW, respectively. 













Figure 2. Characteristics of TIF samples obtained by centrifugation. A and B) Venn 
diagrams representing the overlap among the TIF proteins detected by centrifugation at 
800 g (L) and at 10000 g (H). The numbers indicate identified proteins. C) Heat map of 
Pearson correlation coefficients comparing tumor samples and methods. D) Percentage 
distribution of GO terms related to subcellular categories. The graphic compares the non-













Figure 3. Comparison of the secretome obtained by elution and spin. A) Graphic 
representing the proteins intensity mean in each sample for both methods, elution (El) 
and spin (Sp). B) and C) Venn diagram representing the overlapping in the proteome of 




   
 
overlap among the TIF proteins detected by elution and by spin. The numbers indicate 
identified proteins. E) Heat map of Pearson correlation coefficients comparing tumor 
samples and methods. F) Percentage distribution of GO terms related to subcellular 
categories. The graphic compares the non-overlapping proteins obtained by elution and 
by centrifugation.  
 
Table 1. Patients and tumors characteristics from the 5 analyzed samples.  
Sample Gender Age Tumor localization Tumor size Tumor 
characteristics 
SCC6 Male 90 Wrist 3 cm Primary tumor 
SCC8 Male 84 Scalp 2 cm Primary tumor 
SCC9 Male 80 Face (right cheek) 3’5 cm Primary tumor 
SCC18 Male 80 Face (left cheek) 4 cm Primary tumor 





























Supplementary table 1: Comparisons of the PSMs found in both methods (elution (left) 
and spin at 10000 g (right)) for Albumin (P02768), Serotransferrin (P02787), fibrinogen 
alpha chain precursor (P02671) and fibrinogen beta chain precursor (P02675). Showing 
the associated p-values to the Student t-tests applied to check the statistical significance.  
 
 
Supplementary table 2: Semi-quantitative analysis of ribosomal proteins (based on the 
signal of 78 ribosomal proteins) using the PSMs detected in both extraction methods 
(elution and spin at 10000 g). Showing the associated p-values to the Student t-tests 








   
  
